Vikram Purohit analyst

Currently out of the existing stock ratings of Vikram Purohit, 86 are a BUY (40.38%), 120 are a HOLD (56.34%), 7 are a SELL (3.29%).

Vikram Purohit

Work Performance Price Targets & Ratings Chart

Analyst Vikram Purohit, carries an average stock price target met ratio of 57.82% that have a potential upside of 37.08% achieved within 177 days. Previously, Vikram Purohit worked at MORGAN STANLEY.

Vikram Purohit’s has documented 453 price targets and ratings displayed on 29 stocks. The coverage was on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on RXRX, Recursion Pharmaceuticals at 14-May-2026.

Wall Street Analyst Vikram Purohit

Analyst best performing recommendations are on TAL (TAL EDUCATION GROUP).
The best stock recommendation documented was for TAL (TAL EDUCATION GROUP) at 6/1/2021. The price target of $35 was fulfilled within 2 days with a profit of $5.51 (13.6%) receiving and performance score of 68.01.

Average potential price target upside

AXSM Axsome Therapeutics CERT Certara FHTX Foghorn Therapeutics  HOOK Hookipa Pharma INCY yte KYMR Kymera Therapeutics RDUS Schnitzer Steel Industries SAGE Sage Therapeutic TALS Talaris Therapeutics TBPH Theravance Biopharma EVLO Evelo Biosciences EXAI Exscientia Ltd ADR TIL Instil Bio RGNX Regenxbio SDGR Schrodinger ARQT Arcutis Biotherapeutics  ASND Ascendis Pharma AS AKLI Akili HALO Halozyme Therapeutics BMRN Biomarin Pharmaceutical CMPS Compass Pathways Plc GMAB Genmab AS RXRX Recursion Pharmaceuticals ABVX Abivax SA American Depositary Shares SLRN ACELYRIN, INC. Common Stock ABSI Absci Corp ARGX argenx NV ADR TAL TAL Education Group TSVT 2Seventy Bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jun-2018

$290

$56.2 (24.04%)

$290

6 days ago
(08-Jul-2026)

44/48 (91.67%)

$44.43 (18.09%)

717

Buy Since 25-Jan-2024

$304

$70.2 (30.03%)

$302

7 days ago
(07-Jul-2026)

19/21 (90.48%)

$54.24 (21.72%)

249

Buy Since 14-Apr-2020

$300

$58.33 (24.14%)

$190

26 days ago
(17-Jun-2026)

11/12 (91.67%)

$47.84 (18.97%)

763

Buy Since 03-Sep-2025

$255

$13.33 (5.52%)

$202

2 months 8 days ago
(05-May-2026)

5/5 (100%)

$31.94 (14.32%)

78

Hold Since 05-May-2026

$242

$0.33 (0.14%)

$204

2 months 8 days ago
(05-May-2026)

6/6 (100%)

$18.94 (8.49%)

181

Show more analysts

Please expand the browser size to see the chart

Which stock is Vikram Purohit is most bullish on?

Potential upside of $16.8 has been obtained for HALO (HALOZYME THERAPEUTICS)

Which stock is Vikram Purohit is most reserved on?

Potential downside of $1.94 has been obtained for RXRX (RECURSION PHARMACEUTICALS)

What Year was the first public recommendation made by Vikram Purohit?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?